Back to Journals » International Journal of Nanomedicine » Volume 17

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Retraction]

Authors Rahim H , Sadiq A, Khan S , Amin F, Ullah R, Shahat AA , Mahmood HM

Received 23 November 2022

Accepted for publication 23 November 2022

Published 28 November 2022 Volume 2022:17 Pages 5779—5780

DOI https://doi.org/10.2147/IJN.S398841



Rahim H, Sadiq A, Khan S, et al. Int J Nanomedicine. 2019;14:6287-6296.

The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised about the alleged duplication of regions within the image used in Figure 4A. The authors did respond to our queries but were unable to provide a satisfactory explanation for the alleged duplication. In addition, further analysis of the original image used in Figure 4A indicates that regions within the image may have been altered. The Editor determined that the findings reported in the article were unreliable and requested for the article to be retracted. The authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.